Archive · 19 Nov 2025
India's Diagnostic Services Market to Grow 12% Annually, Reach $16-Bn by 2030
India's diagnostic services market is expected to grow quickly in the next five years.
This is because more people are aware of preventive healthcare, the population is changing, and more people have health insurance.
The market will grow by having more patients and tests.
However, there is strong competition from big companies, so diagnostic chains need to focus on having more patients and working efficiently to make money.
The market is also becoming more organized, with big chains expanding and smaller ones struggling.
Genomic testing is becoming more important, but it requires a lot of investment.
Market expected to grow at 12% CAGR over next five years
Rising preventive healthcare awareness, demographic shifts, and insurance coverage driving growth
Revenue expansion driven by patient volume growth and test samples
Intense competition due to entry of large pharma companies and hospital chains
Volume growth, innovation, and efficiency improvements key to profitability
- Who
- India's diagnostic services market
- What
- expected to grow at 12% CAGR over next five years
- When
- over the next five years
- Where
- in India
- Why
- due to rising preventive healthcare awareness, demographic shifts, and expanding health insurance coverage
Organised Diagnostic Chains
Smaller Standalone Labs and Hospital-Based Centres
Market Share
Organised Diagnostic Chains
20-25%
Smaller Standalone Labs and Hospital-Based Centres
Remaining 75-80%
Profitability
Organised Diagnostic Chains
Sustained due to volume growth and operational efficiency
Smaller Standalone Labs and Hospital-Based Centres
Facing margin pressure and challenges in near to medium term
Expansion
Organised Diagnostic Chains
Into tier-II, III, and IV towns
Smaller Standalone Labs and Hospital-Based Centres
Limited expansion due to resources and competition
- Current Market Size
- around $10 billion
- CAGR
- 12%
- Primary Growth Drivers
- preventive healthcare awareness, demographic shifts, health insurance coverage
- Revenue Expansion Drivers
- patient volume growth (12% CAGR), test samples (17% CAGR)
- Organised Chains Market Share
- 20-25%
- Genomic Testing Growth Driver
- aids in disease diagnosis, cancer treatment planning, drug response prediction, prenatal screening, preventive healthcare decisions